Instrument Inactif

Communiqués RESP HEAL

Actions

RAP

AU000000RAP5

Communiqués

06/08/22	ResApp Health : Pfizer raises scheme consideration to A$0.208 per share	PU
23/07/22	ResApp Health : Study shows efficacy of ResAppDx use with masks	PU
20/07/22	ResApp Health : Clarification - Scheme Booklet registered with ASIC	PU
18/07/22	ResApp Health : Scheme Booklet registered with ASIC	PU
06/07/22	ResApp Health : Cough detection patent granted in Australia and Japan	PU
06/07/22	ResApp Health : receives FDA 510(k) clearance for SleepCheckRx	PU
16/06/22	ResApp Health : Application for quotation of securities - RAP	PU
14/06/22	ResApp Health : Increased Scheme Consideration from Pfizer	PU
26/04/22	ResApp Health : Quarterly Activities Report and Appendix 4C	PU
11/04/22	ResApp Health : Proposed Acquisition of ResApp Health by Pfizer	PU
01/04/22	ResApp Health : Dartford and Gravesham NHS Trust to pilot ResAppDx	PU
22/03/22	ResApp Health : COVID-19 Investor Presentation	PU
21/03/22	ResApp Health : announces positive results for a new novel smartphone-based COVID-19 screening test	PU
16/02/22	ResApp Health : Health Teams to launch ResAppDx on aged care telehealth platform	PU
03/02/22	ResApp Health : Cough analysis patent granted in China	PU
26/01/22	ResApp Health : Further international appointments to COVID-19 Scientific Advisory Board	PU
25/01/22	ResApp Health : ResAppDx goes live with Doctors on Demand in Australia	PU
20/01/22	ResApp Health : Binding LOI signed with Homify to launch ResAppDx in the Philippines	PU
16/01/22	ResApp Health : New publication highlights use of ResAppDx in a COVID-19 fever clinic	PU
13/01/22	ResApp Health : Notification regarding unquoted securities - RAP	PU
22/12/21	ResApp Health : Distribution agreement with Sanrai International for emerging markets	PU
19/12/21	ResApp Health : receives $818,826 in R&D tax incentive refund	PU
09/12/21	ResApp Health : Establishes COVID-19 Scientific Advisory Board	PU
29/11/21	ResApp Health : receives world’s first regulatory approvals for cough counter smartphone application	PU
23/11/21	ResApp Health : completes COVID-19 study recruitment in India	PU